Clinical Significance of Papillary Muscles on Left Ventricular Mass Quantification Using Cardiac Magnetic Resonance Imaging Reproducibility and Prognostic Value in Fabry Disease

被引:9
|
作者
Al-Arnawoot, Amna [1 ]
O'Brien, Ciara [1 ]
Karur, Gauri R. [1 ]
Nguyen, Elsie T. [1 ]
Wasim, Syed [3 ,4 ]
Iwanochko, Robert M. [2 ]
Morel, Chantal F. [3 ,4 ]
Hanneman, Kate [1 ]
机构
[1] Toronto Gen Hosp, Toronto Joint Dept Med Imaging, Toronto, ON, Canada
[2] Univ Hlth Network, Peter Munk Cardiac Ctr, Div Cardiol, Toronto, ON, Canada
[3] Univ Hlth Network, Fred A Litwin Ctr Genet Med, Toronto, ON, Canada
[4] Univ Toronto, Mt Sinai Hosp, Toronto, ON, Canada
关键词
cardiomyopathy; Fabry disease; cardiac magnetic resonance imaging; left ventricular mass; left ventricular hypertrophy; papillary muscle mass; BODY-SIZE; IMPACT; TRABECULAE; DIAGNOSIS;
D O I
10.1097/RTI.0000000000000556
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: Accurate and reproducible assessment of left ventricular mass (LVM) is important in Fabry disease. However, it is unclear whether papillary muscles should be included in LVM assessed by cardiac magnetic resonance imaging (MRI). The purpose of this study was to evaluate the reproducibility and predictive value of LVM in patients with Fabry disease using different analysis approaches. Materials and Methods: A total of 92 patients (44 +/- 15 y, 61 women) with confirmed Fabry disease who had undergone cardiac MRI at a single tertiary referral hospital were included in this retrospective study. LVM was assessed at end-diastole using 2 analysis approaches, including and excluding papillary muscles. Adverse cardiac events were assessed as a composite end point, defined as ventricular tachycardia, bradycardia requiring device implantation, severe heart failure, and cardiac death. Statistical analysis included Cox proportional hazard models, Akaike information criterion, intraclass correlation coefficients, and Bland-Altman analysis. Results: Left ventricular end-diastolic volume, end-systolic volume, ejection fraction, and LVM all differed significantly between analysis approaches. LVM was significantly higher when papillary muscles were included versus excluded (157 +/- 71 vs. 141 +/- 62 g, P<0.001). Mean papillary mass was 16 +/- 11 g, accounting for 10%+/- 3% of total LVM. LVM with pap illary muscles excluded had slightly better predictive value for the composite end point compared with LVM with papillary muscles included based on the model goodness-of-fit (Akaike information criterion 140 vs. 142). Interobserver agreement was slightly better for LVM with papillary muscles excluded compared with included (intraclass correlation coefficient 0.993 [95% confidence interval: 0.985, 0.996] vs. 0.989 [95% confidence interval: 0.975, 0.995]) with less bias and narrower limits of agreement. Conclusions: Inclusion or exclusion of papillary muscles has a significant effect on LVM quantified by cardiac MRI, and therefore, a standardized analysis approach should be used for follow-up. Exclusion of papillary muscles from LVM is a reasonable approach in patients with Fabry disease given slightly better predictive value and reproducibility.
引用
收藏
页码:242 / 247
页数:6
相关论文
共 50 条
  • [21] Left atrial function measured by cardiac magnetic resonance imaging in patients with heart failure: clinical associations and prognostic value
    Pellicori, Pierpaolo
    Zhang, Jufen
    Lukaschuk, Elena
    Joseph, Anil C.
    Bourantas, Christos V.
    Loh, Huan
    Bragadeesh, Thanjavur
    Clark, Andrew L.
    Cleland, John G. F.
    EUROPEAN HEART JOURNAL, 2015, 36 (12) : 733 - +
  • [22] Screening for Fabry disease in patients with hypertrophic cardiomyopathy using cardiac magnetic resonance imaging
    Li, Jialin
    Pu, Lutong
    Xu, Ziqian
    Wan, Ke
    Xu, Yuanwei
    Wang, Jie
    Han, Yuchi
    Chen, Yucheng
    EUROPEAN RADIOLOGY, 2024, : 2888 - 2898
  • [23] Focal But Not Diffuse Myocardial Fibrosis Burden Quantification Using Cardiac Magnetic Resonance Imaging Predicts Left Ventricular Reverse Modeling Following Cardiac Resynchronization Therapy
    Chen, Zhong
    Sohal, Manav
    Sammut, Eva
    Child, Nick
    Jackson, Tom
    Claridge, Simon
    Cooklin, Michael
    O'Neill, Mark
    Wright, Matthew
    Gill, Jaswinder
    Chiribiri, Amedeo
    Schaeffter, Tobias
    Carr-White, Gerry
    Razavi, Reza
    Rinaldi, C. Aldo
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2016, 27 (02) : 203 - 209
  • [24] Left ventricular mass by 12-lead electrocardiogram in healthy subjects:: comparison to cardiac magnetic resonance imaging
    Carlsson, MB
    Trägårdh, E
    Engblom, H
    Hedström, E
    Wagner, G
    Pahlm, O
    Arheden, H
    JOURNAL OF ELECTROCARDIOLOGY, 2006, 39 (01) : 67 - 72
  • [25] Prognostic Value of Left Atrial Volume and Late Gadolinium Enhancement on Cardiac Magnetic Resonance Imaging in Patients with Coronary Artery Disease and Severe Left Ventricular Dysfunction Underwent CABG
    Chen, Wei
    Li, Shuang
    Zhao, Yang
    Gao, YiFeng
    Wang, Rui
    Ren, Yue
    Wang, Hui
    Xu, Lei
    ACADEMIC RADIOLOGY, 2024, 31 (07) : 2695 - 2703
  • [26] Left ventricular mass and systolic function in children with chronic kidney disease—comparing echocardiography with cardiac magnetic resonance imaging
    Raoul Arnold
    Daniel Schwendinger
    Sabine Jung
    Martin Pohl
    Bernd Jung
    Julia Geiger
    Charlotte Gimpel
    Pediatric Nephrology, 2016, 31 : 255 - 265
  • [27] Relation of Alcohol Consumption to Left Ventricular Fibrosis Using Cardiac Magnetic Resonance Imaging
    Voskoboinik, Aleksandr
    Costello, Benedict T.
    La Gerche, Andre
    Prabhu, Sandeep
    Wong, Geoff
    Flannery, Michael D.
    Nalliah, Chrishan
    Sugumar, Hariharan
    Springer, Fabian
    Kalman, Jonathan M.
    Taylor, Andrew J.
    Kistler, Peter M.
    AMERICAN JOURNAL OF CARDIOLOGY, 2019, 123 (03) : 460 - 465
  • [28] Evaluation of Echocardiographic Measures of Left Ventricular Function in Patients with Duchenne Muscular Dystrophy: Assessment of Reproducibility and Comparison to Cardiac Magnetic Resonance Imaging
    Soslow, Jonathan H.
    Xu, Meng
    Slaughter, James C.
    Stanley, Michael
    Crum, Kimberly
    Markham, Larry W.
    Parra, David A.
    JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2016, 29 (10) : 983 - 991
  • [29] Cardiac Magnetic Resonance Assessment of Left Ventricular Mass in Autosomal Dominant Polycystic Kidney Disease
    Perrone, Ronald D.
    Abebe, Kaleab Z.
    Schrier, Robert W.
    Chapman, Arlene B.
    Torres, Vicente E.
    Bost, James
    Kaya, Diana
    Miskulin, Dana C.
    Steinman, Theodore I.
    Braun, William
    Winklhofer, Franz T.
    Hogan, Marie C.
    Rahbari-Oskoui, Frederic
    Kelleher, Cass
    Masoumi, Amirali
    Glockner, James
    Halin, Neil J.
    Martin, Diego
    Remer, Erick
    Patel, Nayana
    Pedrosa, Ivan
    Wetzel, Louis H.
    Thompson, Paul A.
    Miller, J. Philip
    Meyers, Catherine M.
    Bae, K. Ty
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (10): : 2508 - 2515
  • [30] Left ventricular mass and systolic function in children with chronic kidney disease-comparing echocardiography with cardiac magnetic resonance imaging
    Arnold, Raoul
    Schwendinger, Daniel
    Jung, Sabine
    Pohl, Martin
    Jung, Bernd
    Geiger, Julia
    Gimpel, Charlotte
    PEDIATRIC NEPHROLOGY, 2016, 31 (02) : 255 - 265